首页> 美国卫生研究院文献>Interdisciplinary Toxicology >Protection studies of new bis quaternary 2-(hydroxyimino)-N-(pyridin-3yl) acetamide derivatives (HNK-series) oximes against acute poisoning by dichlorvos (DDVP) in Swiss albino mice
【2h】

Protection studies of new bis quaternary 2-(hydroxyimino)-N-(pyridin-3yl) acetamide derivatives (HNK-series) oximes against acute poisoning by dichlorvos (DDVP) in Swiss albino mice

机译:新的双季铵2-(羟基亚氨基)-N-(吡啶-3-基)乙酰胺衍生物(HNK系列)肟的保护研究对瑞士白化病小鼠的敌敌畏(DDVP)急性中毒

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The available antidotal therapy against acute poisoning by organophosphates involves the use of atropine alone or in combination with one of the oximes, e.g. 2-PAM, Obidoxime, TMB-4 or HI-6. Each of these oximes has some limitation, raising the question of the universal antidotal efficacy against poisoning by all OPserve agents. In the present study, newly synthesized bis quaternary 2-(hydroxyimino)-N-(pyridin-3yl) acetamide derivatives (HNK-series) oximes were evaluated for their antidotal efficacy against DDVP intoxicated Swiss mice, in terms of the Protection Index (PI) and AChE reactivation in brain and serum. The inhibition concentration (IC50) was determined in brain and serum after optimizing the time point for maximum inhibition (60 min post DDVP exposure). AChE reactivation efficacy of the HNK series was evaluated at IC50 and compared with 2-PAM. HNK-102 showed a ~2 times better Protection Index (PI) as compared to 2-PAM against DDVP toxicity. IC50 at 60 min DDVP post exposure was found to be approximately one fifth and one half of the LD50 dose for brain and serum AChE, respectively. Out of three HNK oximes, HNK-102 & 106 at 0.20 LD50 dose significantly reactivated DDVP intoxicated brain AChE (p<0.05) as compared to 2-PAM at double IC50 dose of DDVP. In light of double PI and higher AChE reactivation, HNK 102 was found to be a better oxime than 2-PAM in the treatment of acute poisoning by DDVP.
机译:针对有机磷酸盐引起的急性中毒的可用解毒疗法涉及单独使用阿托品或与其中一种肟(例如苯丙氨酸)合用阿托品。 2-PAM,Obidoxime,TMB-4或HI-6。这些肟中的每一种都有一定的局限性,这引发了针对所有OP /神经毒剂中毒的普遍解毒功效的问题。在本研究中,根据保护指数(PI),评估了新合成的双季2-(羟基亚氨基)-N-(吡啶-3基)乙酰胺衍生物(HNK系列)肟对DDVP中毒瑞士小鼠的解毒功效。 )和大脑和血清中的AChE激活。在优化最大抑制时间(DDVP暴露后60分钟)后,测定大脑和血清中的抑制浓度(IC50)。在IC50上评估了HNK系列的AChE激活功效,并与2-PAM进行了比较。与2-PAM抗DDVP毒性相比,HNK-102的保护指数(PI)约高2倍。发现暴露后60分钟DDVP的IC50分别约为大脑和血清AChE的LD50剂量的五分之一和一半。在三种HNK肟中,以0.20 LD50剂量使用HNK-102和106可显着重新激活DDVP中毒的大脑AChE(p <0.05),而用2-ICM则用DDVP的两倍IC50剂量。考虑到双PI和更高的AChE活化,在用DDVP治疗急性中毒中,发现HNK 102是一种优于2-PAM的肟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号